Hook & thesis
Sonida Senior Living is no longer a restructuring story; the hard part is done. Recent results tied to the $1.8 billion CNL Healthcare Properties acquisition produced a material revenue bump and stabilization in occupancy. With an activist investor materially increasing its stake, Sonida now has a credible path to compounding cash flows rather than headline-driven volatility. That creates an asymmetric trade: the company still carries merger and refinancing risk, but the market seems to be pricing in much of the recovery already — leaving room for steady upside if operations continue to improve.
My trade thesis: enter a disciplined long position at $33.00, target $45.00 and place a stop at $28.00. The plan is a long-term trade over roughly 180 trading days (about nine months) to allow the merger synergies, occupancy gains and any refinancing actions to show up in operating results and cash flow.
What Sonida does and why the market should care
Sonida Senior Living operates senior housing communities providing independent living, assisted living and memory care. The business model is fundamentally real-estate-plus-services: recurring cash flows come from resident fees and occupancy, while profitability depends on operating leverage, cost control and effective capital allocation for facilities. Investors should care because senior housing is a scale-sensitive industry — occupancy and rate improvements can compound revenue quickly across a large portfolio, and Sonida just enlarged its scale materially through the CNL Healthcare Properties acquisition.
Evidence behind the turnaround
There are concrete signs the turnaround is real. Public reporting and investor commentary show a 30% year-over-year revenue lift after the acquisition and higher occupancy into 2026. The market has already rewarded that progress — the stock is up roughly 45% over the past year — but the improvements are operational, not purely financial engineering: occupancy recovery plus integration of CNL assets is driving the revenue step-up.
Key balance-sheet and market numbers investors should note:
- Market capitalization roughly $1.57 billion and enterprise value about $3.11 billion, reflecting material debt on the balance sheet.
- Price-to-book near 1.77 and price-to-sales around 3.81, showing the market values both the asset base and the revenue stream.
- Profitability metrics are still challenged: trailing EPS is negative at -$2.62 and free cash flow was negative $85.2 million in the most recent period.
- Leverage is meaningful: debt-to-equity of 1.83 and a current ratio around 0.41, so liquidity and refinancing timing are important.
Valuation framing
Valuation is mixed: on one hand, price-to-book at 1.77 and a 52-week low of $23.66 suggest there is value in the underlying assets if management can convert occupancy and rates to steady FCF. On the other hand, EV-to-sales of 7.55 and EV/EBITDA of 63.48 are elevated, a function of negative earnings and the recent acquisition inflating enterprise value while earnings catch up.
Put simply: the market is paying for future cash flow normalization. That makes Sonida a classic “recovery compounding” situation — upside depends on execution and refinancing, not a pure multiple re-rating. If Sonida can stabilize margins and turn free cash flow positive, multiples should compress to more typical REIT/senior-living levels and deliver significant upside; if earnings remain negative and debt servicing stress increases, downside risk is meaningful.
Catalysts to drive the trade
- Operational integration and synergies - Realized cost synergies and standardized operating procedures across the combined Sonida/CNL portfolio should lift margins over time.
- Occupancy and rate momentum - Continued occupancy improvement and modest rate growth will leverage fixed costs and expand EBITDA.
- Activist/strategic investor support - Conversant Capital materially increased its stake on 05/16/2026, signaling committed capital and likely governance support for value-creation initiatives.
- Refinancing of the bridge facility - Successful refinancing in 2027 at sensible terms would de-risk the balance sheet and remove a significant overhang; progress toward pre-funding or terming out short-dated obligations would be a major positive.
- Legal clarity - Resolution or dismissal of M&A-related shareholder litigation would remove an uncertainty that could otherwise cap the multiple.
Trade plan
Entry: $33.00
Target: $45.00
Stop loss: $28.00
Horizon: long term (180 trading days). I expect this trade to need time for the combined entity to convert revenue gains into positive free cash flow, for occupancy trends to sustain and for any refinancing discussions to progress. The entry is near the current market price to capture upside from continued operational execution. The stop is set to limit losses if occupancy or integration deteriorates or if the market re-prices the stock on financing stress.
Position management note: scale in moderately at the entry, add on a confirmed earnings beat or publicized successful refinancing step, and consider trimming on a strong run toward $39.66 (52-week high) to lock profits. If results stall, tighten stops or reassess based on liquidity metrics and legal outcomes.
Technical and market context
Short interest has risen as the story evolved, with the most recent settlement showing roughly 1.18 million shares short and days-to-cover under two, so short squeezes are possible but not deeply destabilizing. Momentum indicators (RSI around 37 and bearish MACD histogram) show the stock has downside room but is not overbought — a reasonable entry for a long-term compounding play rather than a momentum chase.
Risks and counterarguments
- High leverage and refinancing risk - Debt-to-equity of 1.83 and an outstanding bridge facility due in 2027 create a material refinancing requirement. If credit conditions remain tight or rates stay elevated, refinancing could be costly or dilutive.
- Negative profitability and cash burn - Trailing EPS is -$2.62 and free cash flow was negative $85.2 million; until Sonida turns the FCF line positive, valuation is hostage to market sentiment and funding availability.
- M&A and litigation overhangs - Multiple law firms have investigated the merger, and shareholder litigation can create noise, delay integration benefits and increase costs.
- Operational execution risk - Occupancy momentum is a leading driver of value. If demand softens or if integration costs exceed estimates, margin recovery could stall.
- Counterargument: valuation may already be stretched. EV/EBITDA north of 60 and negative EPS argue the market has priced in substantial future improvement; if Sonida stumbles, the downside could be sharp.
What would change my mind
I would become more bullish if Sonida reports consecutive quarters of positive free cash flow, reduces leverage materially through a refinance or asset sales, and provides quantified synergy realization commensurate with acquisition guidance. Conversely, I would reduce exposure or flip bearish if the company misses occupancy targets, if refinancing terms are punitive or if litigation leads to material dilution or cash outflows.
Conclusion
Sonida is a pragmatic compounding opportunity: the operational heavy lifting looks largely complete, and the company has both scale and an influential investor actively backing the story. That said, the business carries real balance-sheet and legal risk that can derail the recovery. The trade laid out here balances those realities with a disciplined entry, a sensible stop and a target that assumes steady execution and successful refinancing. This is not a quick flip — it is a position sized for a patient, evidence-driven investor who wants to capture compounding upside as the business converts occupancy and revenue gains into durable cash flow.
Buy entry: $33.00. Target: $45.00. Stop: $28.00. Horizon: long term (180 trading days).